PLGA - encapsulated harmine derivative H-2-168: A promising therapeutic agent for mitigating liver damage in hepatic hydatid disease

• Ayinula Tuohetali ,

  Contributed equally to this work with: Ayinula Tuohetali, Bei Chen

  Roles Data curation, Investigation, Methodology, Writing – original draft

  Affiliations State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Department of Pharmacy, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China, College of Veterinary Medicine, Xinjiang Agricultural University, Urumqi, China

  ⨯
• Bei Chen ,

  Contributed equally to this work with: Ayinula Tuohetali, Bei Chen

  Roles Methodology, Writing – review & editing

  Affiliation State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Department of Pharmacy, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China

  ⨯
• Qinwei Xu,

  Roles Formal analysis

  Affiliation State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Department of Pharmacy, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China

  ⨯
• Jiang Zhu,

  Roles Writing – review & editing

  Affiliation Department of Abdominal Surgery, The Third People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China

  ⨯
• Zhenping Zhang,

  Roles Methodology, Writing – review & editing

  Affiliation College of Veterinary Medicine, Xinjiang Agricultural University, Urumqi, China

  ⨯
• Xia Chen,

  Roles Software

  Affiliation College of Veterinary Medicine, Xinjiang Agricultural University, Urumqi, China

  ⨯
• Yixueying Ma,

  Roles Investigation, Methodology

  Affiliation State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Department of Pharmacy, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China

  ⨯
• Kadierya Kuerban,

  Roles Visualization

  Affiliation State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Department of Pharmacy, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China

  ⨯
• Kalibixiati Aimulajiang ,

  Roles Writing – review & editing

  * E-mail: kali0920@163.com (KA); ghj_0630@163.com (HG)

  Affiliations State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Department of Pharmacy, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China, Clinical Medicine Institute, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China

  ⨯
• Huijing Gao

  Roles Funding acquisition, Methodology, Supervision, Writing – review & editing

  * E-mail: kali0920@163.com (KA); ghj_0630@163.com (HG)

  Affiliation State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Department of Pharmacy, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China

  https://orcid.org/0000-0003-1910-5075

  ⨯